Form 8.3 - WILLIS TOWERS WATSON PLC

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 09 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

1,674,769

1.30%

190,397

0.15%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

102,359

0.08%

7,100

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,783,228

1.38%

203,597

0.16%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

5

238.8900 USD

Purchase

18

238.9700 USD

Purchase

27

239.4400 USD

Purchase

33

239.4500 USD

Purchase

36

237.2280 USD

Purchase

40

239.3900 USD

Purchase

43

239.9000 USD

Purchase

100

238.8100 USD

Purchase

100

237.6100 USD

Purchase

150

239.3816 USD

Purchase

171

239.2194 USD

Purchase

200

238.6450 USD

Purchase

632

238.0700 USD

Purchase

953

239.2677 USD

Purchase

2,507

238.9603 USD

Purchase

2,980

239.4197 USD

Purchase

3,276

239.1303 USD

Purchase

3,457

239.1485 USD

Purchase

5,702

238.9753 USD

Purchase

6,851

239.8577 USD

Purchase

9,193

239.3118 USD

Purchase

12,822

239.9800 USD

Sale

6

239.1000 USD

Sale

6

239.0600 USD

Sale

6

239.1850 USD

Sale

12

239.5475 USD

Sale

18

239.1133 USD

Sale

20

239.5140 USD

Sale

30

239.1110 USD

Sale

36

239.0050 USD

Sale

39

239.9600 USD

Sale

50

239.2850 USD

Sale

54

237.2280 USD

Sale

100

238.9100 USD

Sale

100

238.4800 USD

Sale

100

237.6600 USD

Sale

100

238.9300 USD

Sale

100

239.8700 USD

Sale

105

238.8900 USD

Sale

140

239.0400 USD

Sale

159

238.9574 USD

Sale

185

239.1197 USD

Sale

200

238.0700 USD

Sale

300

239.8833 USD

Sale

300

239.3813 USD

Sale

303

239.9686 USD

Sale

500

238.9907 USD

Sale

500

239.1680 USD

Sale

746

239.5893 USD

Sale

1,055

239.3201 USD

Sale

1,100

238.4836 USD

Sale

1,176

239.5855 USD

Sale

1,299

238.9459 USD

Sale

1,848

238.8966 USD

Sale

2,414

239.0766 USD

Sale

2,776

239.1235 USD

Sale

4,323

239.0935 USD

Sale

4,741

239.5782 USD

Sale

5,655

239.0961 USD

Sale

6,851

239.8577 USD

Sale

11,843

239.9800 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

12 Apr 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 734950
Time of Receipt (offset from UTC): 20210412T131105+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC